Dermapharm Holding SE (DMP) — Free Cash Flow Generation Index
Dermapharm Holding SE (DMP) has a Free Cash Flow Generation Index of 0.70x as of March 2026. Free cash flow of €27.65 Million represents 1% of operating cash flow (€39.49 Million). Read how much debt does Dermapharm Holding SE carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dermapharm Holding SE Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Dermapharm Holding SE across 12 annual periods. Explore Dermapharm Holding SE capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Dermapharm Holding SE (2014–2025)
Year-by-year Free Cash Flow Generation Index for Dermapharm Holding SE. For the full company profile including market capitalisation, see Dermapharm Holding SE stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | €139.39 Million | €181.51 Million | €42.12 Million | ▼ -5.2% |
| 2024 | 0.81x | €163.14 Million | €201.38 Million | €38.24 Million | ▼ -0.1% |
| 2023 | 0.81x | €177.88 Million | €219.42 Million | €41.54 Million | ▼ -6.3% |
| 2022 | 0.86x | €249.52 Million | €288.53 Million | €39.01 Million | ▲ +14.5% |
| 2021 | 0.76x | €189.16 Million | €250.37 Million | €61.20 Million | ▲ +9.7% |
| 2020 | 0.69x | €90.30 Million | €131.10 Million | €40.80 Million | ▲ +27.9% |
| 2019 | 0.54x | €54.17 Million | €100.61 Million | €46.44 Million | ▼ -35.7% |
| 2018 | 0.84x | €133.16 Million | €159.13 Million | €25.97 Million | ▲ +503.8% |
| 2017 | 0.14x | €12.02 Million | €86.74 Million | €74.72 Million | ▼ -82.0% |
| 2016 | 0.77x | €59.02 Million | €76.78 Million | €17.76 Million | ▲ +22.0% |
| 2015 | 0.63x | €25.44 Million | €40.38 Million | €14.93 Million | ▲ +32.4% |
| 2014 | 0.48x | €25.83 Million | €54.26 Million | €28.42 Million | — |